TAB2 and Alzheimer disease: However, the DGKG expression profile was contradictory to our aforementioned results; furthermore, we found that the expression levels of MAP3K7IP2 and NFKBIE in the AD group were not significantly different from those in the WT group (Figures 7A–E).